Our finding provides mechanistic insights into the adverse impact of hyperglycemia on pancreatic carcinogenesis and demonstrates the value of targeting AMPK-Bmi1-GATA2-MICA/B axis as potential windows for immunotherapeutic interventions. Here, MICA is linked to Hyperglycemia.